The role of TrpC5 is also clinically relevant; for example, in breast cancer patients undergoing treatment with doxorubicin, TrpC5 expression levels are significantly higher in those with progressive disease compared to patients with partial or complete response [47]. This evidence concerns the gene TRPC5 and breast carcinoma.